The future of cancer verification lies in advancements in technology and personalized medicine. Improved biomarkers and liquid biopsies, which detect cancer cells or DNA in the blood, are promising tools for early and accurate diagnosis. Artificial intelligence and machine learning are also being explored to enhance the accuracy of imaging and pathological analysis.
